N
Neal Dunlap
Researcher at University of Louisville
Publications - 132
Citations - 2926
Neal Dunlap is an academic researcher from University of Louisville. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 20, co-authored 120 publications receiving 2092 citations. Previous affiliations of Neal Dunlap include University of Virginia.
Papers
More filters
Journal ArticleDOI
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison,Andy Trotti,Jonathan Harris,Avraham Eisbruch,Paul M. Harari,David J. Adelstein,Richard C.K. Jordan,Weiqiang Zhao,Erich M. Sturgis,Barbara Burtness,John A. Ridge,Jolie Ringash,James M. Galvin,Min Yao,Shlomo A. Koyfman,Dukagjin Blakaj,Mohammed A. Razaq,A. Dimitrios Colevas,Jonathan J. Beitler,Christopher U. Jones,Neal Dunlap,Samantha A. Seaward,Sharon A. Spencer,Thomas J. Galloway,Jack Phan,James J. Dignam,James J. Dignam,Quynh-Thu Le +27 more
TL;DR: After median follow-up duration of 4·5 years, radiotherapy plus cetuximab did not meet the non-inferiority criteria for overall survival, and patients were stratified by T category (T1-T2 vs T3-T4), N category (N0-N2a vs N2b-N3), Zubrod performance status (0 vs 1), and tobacco smoking history (≤10 pack-years).
Journal ArticleDOI
Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
Neal Dunlap,Jing Cai,G.B. Biedermann,Wensha Yang,Stanley H Benedict,Ke Sheng,Tracey E. Schefter,Brian D. Kavanagh,James M. Larner +8 more
TL;DR: The development of CW toxicity is clinically relevant, and the CW should be considered an organ at risk in treatment planning and limited to <30 cm(3), if possible, to reduce the risk of toxicity without compromising tumor coverage.
Journal ArticleDOI
Pathophysiology of Radiation-Induced Dysphagia in Head and Neck Cancer.
TL;DR: The goal of this review is to discuss the pathophysiology of radiation-induced injury and elucidate areas that need further exploration and improve options available for dysphagia treatment.
Journal ArticleDOI
Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
Neal Dunlap,James M. Larner,Paul W. Read,Benjamin D. Kozower,Christine L. Lau,Ke Sheng,David R. Jones +6 more
TL;DR: Stereotactic body radiation therapy for T2 non-small-cell lung cancer has a higher local recurrence rate and trended toward a worse survival than did T1 lesions, and tumor size is an important predictor of response to stereotacticBody radiation therapy and should be considered in treatment planning.
Journal ArticleDOI
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937
Elizabeth Gore,Chen Hu,Alexander Y. Sun,Daniel F. Grimm,Suresh S. Ramalingam,Neal Dunlap,Kristin Higgins,Maria Werner-Wasik,Aaron M. Allen,Puneeth Iyengar,Gregory M.M. Videtic,Russell K. Hales,Ronald C. McGarry,James J. Urbanic,Anthony T. Pu,Candice Johnstone,Volker W. Stieber,Rebecca Paulus,Jeffrey D. Bradley +18 more
TL;DR: OS exceeded predictions for both arms and crossed the futility boundary for OS and was closed before meeting the accrual target.